Table 3.
Adverse events | Grade 1 or 2 | Grade 3 or 4 |
---|---|---|
Hand-foot syndrome | 8 (23%) | 12 (34%) |
Fatigue | 17 (49%) | 6 (17%) |
Rash | 13 (37%) | 4 (11%) |
Emesis | 10 (29%) | 4 (11%) |
Hypertension | 7 (20%) | 4 (11%) |
Nausea | 18 (51%) | 3 (9%) |
Arthralgias | 6 (17%) | 3 (9%) |
Diarrhea | 20 (57%) | 2 (6%) |
Dehydration | 1 (3%) | 2 (6%) |
Infection | 1 (3%) | 2 (6%) |
Anorexia | 10 (29%) | 1 (3%) |
Headache | 8 (23%) | 1 (3%) |
Mucositis | 7 (20%) | 1 (3%) |
Elevated liver function tests | 6 (17%) | 1 (3%) |
Rigors/chills | 4 (11%) | 1 (3%) |
Joint function | 3 (9%) | 1 (3%) |
Neutropenia | 2 (6%) | 1 (3%) |
Dyspnea | 2 (6%) | 1 (3%) |
Acne | 1 (3%) | 1 (3%) |
Hypotension | 1 (3%) | 1 (3%) |
Hypophosphatemia | 0 | 1 (3%) |
Thrombosis | 0 | 1 (3%) |
Urticaria | 0 | 1 (3%) |
Pleural effusion | 0 | 1 (3%) |
Alopecia | 18 (51%) | 0 |
Pain—other | 17 (48%) | 0 |
Constipation | 10 (29%) | 0 |
Pruritus/itching | 10 (29%) | 0 |
Sensory neuropathy | 9 (26%) | 0 |
Weight loss | 9 (26%) | 0 |